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Incidence, Risk Factors, and Outcome
of Traumatic Tricuspid Regurgitation After
Percutaneous Ventricular Lead Removal
Frédéric Franceschi, MD,* Franck Thuny, MD,* Roch Giorgi, MD, PHD,† Islem Sanaa, MD,*
Eric Peyrouse, MD,* Xavier Assouan, MD,* Sébastien Prévôt, MD,* Emilie Bastard, MD,*
Gilbert Habib, MD,* Jean-Claude Deharo, MD*
Marseilles, France
Objectives This study sought to evaluate the incidence, risk factors, and outcome of traumatic tricuspid regurgitation (TTR)
induced by percutaneous removal of chronically implanted transvenous leads.
Background Although lead removal using modern tools has been shown to be highly effective and safe, TTR has not been
systematically evaluated.
Methods All patients undergoing ventricular lead removal at our center were studied. Lead removal was performed by
simple traction, laser sheath, and/or lasso technique. Presence of a new TTR after removal was assessed by
transthoracic echocardiography. Pre-defined clinical and technical parameters were studied for their association
with TTR. Patients were followed up by outpatient visits.
Results We removed 237 ventricular leads in 208 patients. Median time from lead implantation was 46.4 months (range 0.7
to 260.5 months). A TTR occurred in 19 patients (9.1%), severe in 14. Three independent risk factors of TTR were
found: use of laser sheath (p  0.004), use of both laser sheath and lasso (p  0.02), and female sex (p  0.02).
After a follow-up of 4,130 person-months (median 17.9 months), 5 TTR patients were medically treated for new right-
sided heart failure symptoms, 2 had undergone surgical repair of the tricuspid valve, and 6 had died (2 from heart
failure and 4 from noncardiac causes). Right-sided heart failure occurred only in patients with severe TTR.
Conclusions This study found that TTR is not uncommon after percutaneous lead removal. It is strongly associated with the use of addi-
tional tools beyond simple traction and also with female sex. In the long term, right-sided heart failure is frequent in pa-
tients with severe TTR. (J Am Coll Cardiol 2009;53:2168–74) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.045b
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Phe number of patients with permanent pacemakers or
mplantable cardioverter-defibrillators (ICDs) has increased
arkedly over the last 20 years (1,2). Therefore, an increas-
ng number of lead removal procedures are required. Be-
ause manual traction is often ineffective for removal of
eads implanted for a long time, percutaneous lead removal
ools have been developed (3,4). They have been shown to
e highly effective, although large-scale studies have em-
hasized a small risk of major complications possibly asso-
iated with their use, mainly cardiac tamponade or vessel
aceration (5,6). Other complications that do not carry an
mmediate risk for the patients have not been thoroughly
valuated. Because the fibrous attachments to surrounding
tructures involve the tricuspid valve, valvular damage may
rom the *Cardiology Department and †Epidemiology and Biostatistics Department,
niversity Hospital La Timone, Marseilles, France.c
Manuscript received December 2, 2008; revised manuscript received February 23,
009, accepted February 24, 2009.e provoked by lead removal. Indeed, traumatic tricuspid
egurgitation (TTR) was occasionally described once per-
utaneous lead removal had been performed using various
echniques (6–9). It was mainly recognized because of severe
linical consequences and has not been systematically evaluated
n large series to date. Little is known about this complication
n the era of modern percutaneous lead removal.
Our hypothesis was that TTR might occur in a signifi-
ant number of patients after percutaneous removal of
entricular leads and that it may be influenced by patient-
elated or technical factors. We designed a prospective
ingle-center study to evaluate the incidence, risk factors,
nd outcome of TTR induced by percutaneous lead removal
rocedures performed with modern tools.
ethods
atient population. We included in the study all of the
onsecutive patients from whom at least 1 ventricular lead was
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pril 2008. Patients who had experienced a previous lead
emoval procedure, either successful or not, were not included
n the study. Patients were informed about the study and gave
ritten consent. The study was approved by the ethics com-
ittee of our academic hospital.
ead extraction technique. All removal procedures were
erformed in the operating room or the electrophysiology
aboratory, under general anesthesia or heavy sedation. The
rocedures were performed by 3 experienced operators
J-C.D., F.F., X.A.). Our stepwise approach for lead re-
oval was as follows: 1) When the lead was long enough to
e reached from the device pocket, gentle traction was
pplied on the lead from the pocket. For leads implanted
ore than 6 months prior, the traction was performed after
ntroduction of a locking stylet into the lead lumen (LLD,
pectranectics, Colorado Springs, Colorado). 2) When
emoval by simple traction was not successful, we used at
east 1 of the following tools: laser sheath (SLS II, Spec-
ranectics) or lasso (either Amplatz Goose Neck Snare kit,
v3 Inc., Plymouth, Minnesota, or Needle’s Eye Snare
etrieval Set, Cook, Leechburg, Pennsylvania). The choice
etween these tools was left to the operator, lasso techniques
eing mainly used when the lead had been detached from
he endocardium by traction, or was too short for being
xtracted from the pocket. Lasso was also used rather than
aser sheath when the lead was detached but not easily
emovable through the laser sheath, or when it was broken
uring laser removal attempt.
Removal procedures were terminated after complete re-
oval of the leads or when lead fragments could not be
emoved. The procedural success was defined according to
he criteria of the North American Society of Pacing and
lectrophysiology (10).
Pacemaker-dependent patients were equipped with an
picardial right ventricular pacemaker in the days preceding
he removal procedure. The others were reimplanted when
eeded, after several days or weeks, depending on the
ndication of removal.
tudy design. Before lead removal, all patients underwent
ransthoracic echocardiography (TTE) and/or transesopha-
eal echocardiography (TEE), as previously described (11).
he presence and quantification of a pre-existent tricuspid
egurgitation (TR) was evaluated at that time, along with
ight ventricular function and dimensions. Lead-related
nfective endocarditis was also diagnosed at that time as
efinite or possible according to the Duke criteria (12,13),
r in the presence of lead or valve vegetation. Vegetation
as defined as an oscillating intracardiac mass on the
lectrode leads, cardiac valve leaflets, or endocardial surface
n the setting of valve or lead infection confirmed by
maging in more than 1 echocardiographic plane, and
ositive blood and/or lead tip cultures (14). A complete
TE study was performed before patient discharge, as part
f the study protocol, to detect new tricuspid valve damage.
ollow-up data were collected for all patients. eCHOCARDIOGRAPHIC EVALUA-
ION OF THE TRICUSPID VALVE
ND THE RIGHT VENTRICLE. For
valuation of TR, comprehensive
TE was consistently performed
hroughout the study period with
Vivid 7 apparatus (GE Medical
ystems, Milwaukee, Wiscon-
in). The TEE was performed
ith the same apparatus, only in
ases of poor acoustic windows
y TTE. Echocardiographic
valuation was performed before
nd after lead removal in each
atient by the same operator
F.T. or G.H.). A TR was con-
idered to be related to lead re-
oval, and called TTR, when the early post-removal TEE
howed the apparition of a new flail leaflet as the mecha-
ism of TR. Although flail leaflet is usually associated with
evere TR, the severity was confirmed with an integrative
pproach as recommended by the international guidelines
15). The TR severity was ranked according to the interna-
ional guidelines criteria and classified as mild, moderate, or
evere (15). These qualitative, semiquantitative, and quan-
itative parameters were used: the visualization of chordae or
apillary muscle rupture, a vena contracta with 0.7 cm, or
flow convergence radius 0.9 cm (with a baseline shift with
yquist limit of 28 cm/s).
Right ventricular dilation was assessed at follow-up TEE
nd defined as either a right ventricle end-diastolic
iameter 43 mm in the short axis view, or a ratio of
ight ventricle to left ventricle end-diastolic area 0.6 in
he 4-chamber view.
ISK FACTORS OF TTR. Risk factors were a priori defined on
he basis of current knowledge. They included demographic
ata of the patients, characteristics of implanted device,
resence of a previous TR, number and characteristics of the
mplanted ventricular leads, removal technique and out-
ome, and presence of a lead-related infective endocarditis.
OLLOW-UP. When a TTR was observed, the patients were
ubmitted to clinical follow-up every 6 months and an
nnual TTE to detect clinical signs of right-sided heart
ailure and to evaluate right ventricular dimensions and
unction. For the other patients, clinical and mortality data
ere collected, during an outpatient visit or by telephone, at
he end of the study.
tatistical analysis. No sample size determination has
een performed because no large-scale data were available
bout TTR induced by percutaneous removal of chronically
mplanted transvenous leads. Therefore, all of the consecu-
ive patients who fulfilled the selection criteria were in-
luded in the study. The relation between categorical
ariables and TTR was studied by chi-square test or Fisher
Abbreviations
and Acronyms
CI  confidence interval
HR  hazard ratio
ICD  implantable
cardioverter-defibrillator
OR  odds ratio
TEE  transesophageal
echocardiography
TR  tricuspid
regurgitation
TTE  transthoracic
echocardiography
TTR  traumatic tricuspid
regurgitationxact test, when appropriate. Mann-Whitney U test was
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Lead Removal and Tricuspid Regurgitation June 9, 2009:2168–74sed for continuous variables. Logistic regression with a
orward stepwise approach (p  0.10 as the threshold for
ntering or removing variables) was used to identify the
ndependent risk factors of TTR and to calculate adjusted
dds ratios (ORs) and their 95% confidence intervals (CIs).
he crude effect of TTR on overall mortality was estimated
y the Kaplan-Meier method, and survival curves were
ompared with the log-rank test. Then, a Cox proportional
azards model was used to calculate the hazard ratio (HR),
nd its 95% CI associated with the TTR adjusted for
re-defined prognostic factors: patient age, type of im-
lanted device (i.e., pacemaker or ICD), presence of resyn-
hronization therapy, and lead-related endocarditis as an
ndication for lead removal. The proportional hazards assump-
ion was assessed using Schoenfeld residuals. All statistical tests
ere 2-sided, and the threshold for statistical significance was
 0.05. Analyses were performed with SPSS software
version 15.0, SPSS Inc., Chicago, Illinois).
esults
t our center, during the study period, 208 patients had a first
rocedure of removal of at least 1 ventricular lead. Four
undred and fifty leads were removed in these patients. Two
undred and thirty-seven were ventricular leads and are the
ubject of the present study. A single ventricular lead was
emoved in 180 patients, 2 in 27, and 3 in 1. Three patients
ad removal of both ventricular defibrillating and pacing leads.
ll of the pacemaker or ICD generators were implanted in the
re-pectoral region. The number of pacemaker or ICD gen-
rators that had been implanted per patient was: 1 generator in
13 patients, 2 in 60, more than 2 in 22, and unknown in 13.
atient Characteristics (n  208)
Table 1 Patient Characteristics (n  208)
Male sex 151 (72.6)
Age, yrs, mean  SD 69.8  15.0
Resynchronization therapy 30 (14.4)
Device implanted in the left pre-pectoral region 135 (64.9)
Primary indication for implantation
Atrioventricular block 94 (45.2)
Sinus node disease 42 (20.2)
Primary prevention of sudden cardiac death 35 (16.8)
Documented VT/VF 30 (14.4)
Unknown 7 (3.4)
Implanted device: pacemaker/ICD 151 (72.6)/57 (27.4)
Presence of TR before lead extraction 25 (12.0)
Structural heart disease
Ischemic heart disease 62 (29.8)
Systemic hypertension 44 (21.2)
Idiopathic dilated cardiomyopathy 36 (17.3)
Valvular heart disease 16 (7.7)
Congenital heart disease 5 (2.4)
None 45 (21.6)
alues are n (%) unless otherwise indicated.
ICD  implantable cardioverter-defibrillator; TR  tricuspid regurgitation; VT/VF  ventricular
achycardia/ventricular fibrillation.
Vo patient had a moderate or severe TR or a flail leaflet before
ead removal. Other patient characteristics are presented in
able 1. Lead characteristics are presented in Table 2.
Table 3 is a patient-based presentation of the indications
or lead removal, the tools used, and the outcome of the
rocedure. When multiple ventricular leads were removed
n the same patient, the mentioned tools are the ones used
uring the procedure, for any of the ventricular leads.
TR incidence and risk factors. The post-removal TEE
as performed 1 to 8 days after the procedure. Among the
08 patients, 19 (9.1%) had a TTR. The TTR was
oderate in 5 patients and severe in 14; no patient had a
ild TTR.
Univariate and multivariate analysis of the pre-defined
redictors of TTR are presented in Table 4. In case of
emoval of multiple ventricular leads, the effects of lead
xation, lead polarity, and number of coils were studied only
entricular Lead Characteristics (n  237)
Table 2 Ventricular Lead Characteristics (n  237)
Defibrillating leads
Single coil 15 (6.3)
Double coil 45 (19.0)
Pacing leads
Unipolar 32 (13.5)
Bipolar 144 (60.8)
Tripolar 1 (0.4)
Lead fixation
Active 63 (26.6)
Passive 174 (73.4)
Time from implantation (months) 46.4 (0.7–260.5)
alues are leads, n (%) or median (range).
ead Removal Indications,chniques, and Outcomes
Table 3 Lead Removal Indications,Techniques, and Outcomes
Indication for extraction
Lead-related endocarditis 87 (41.8)
Pocket infection 40 (19.2)
Pocket erosion 25 (12.0)
Lead dysfunction 26 (12.1)
Upgrading from pacemaker to ICD 16 (7.7)
Nonfunctional lead 9 (4.3)
Treatment of ipsilateral breast malignancy 2 (1)
Symptomatic venous occlusion 2 (1)
Heart perforation 1 (0.5)
Extraction technique
Traction only (with or without locking stylet) 99 (47.6)
Additional tools 109 (52.4)
Laser only 75 (36.0)
Lasso only 22 (10.6)
Laser and lasso 12 (5.8)
Laser sheath size
14-F 36 (17.3)
16-F 51 (24.5)
Complete removal 186 (89.4)alues are patients, n (%).
ICD  implantable cardioverter-defibrillator.
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June 9, 2009:2168–74 Lead Removal and Tricuspid Regurgitationhen the same factor was present for all removed leads (i.e.,
n 180 leads for fixation, 129 leads for polarity, and 50 leads
or number of coils).
NIVARIATE ANALYSIS. Five factors were significantly associ-
ted with the occurrence of TTR: use of laser sheath beyond
imple traction was the most significant predictor (OR:
0.17, 95% CI: 2.16 to 94.74, p  0.001); use of any
dditional tool (either laser sheath, lasso, or both) beyond
imple traction (OR: 8.96, 95% CI: 2.02 to 81.45,
 0.001); 2 leads extracted per patient (OR: 4.67, 95%
I: 1.38 to 14.48, p  0.003); female sex (OR: 3.36, 95%
I: 1.14 to 9.90, p  0.01); and a longer time from lead
mplantation (OR: 1.01, 95% CI: 1.00 to 1.01, p  0.03)
Table 4). There was a trend toward a significant association
ith the use of both laser sheath and lasso (OR: 9.70, 95%
I: 0.61 to 141.62, p  0.06).
ULTIVARIATE ANALYSIS. Independent predictors of TTR
ere: use of laser sheath as a single technique beyond
raction (p  0.004); use of both laser sheath and lasso
p  0.02); and female sex (p  0.02) (Table 4).
ollow-up and survival. The 208 patients were followed
p for 4,130 person-months (median 17.9 months, range
.03 to 81.4 months), during which 32 (15.4%) died. In the
on-TTR population, 26 patients (13.7%) died: 10 from
evere sepsis, 8 from pre-existing heart failure, 3 from
udden cardiac death, 1 from stroke, 1 from neoplasia, 1
rom renal failure, and 3 from an unexplained cause. Among
tudied Risk Factors for TTR in Univariate and Multivariate Analysi
Table 4 Studied Risk Factors for TTR in Univariate and Multiva
No TTR
Patient-related factors
Sex (female/male) 47/142
Age, yrs, mean  SD 69.94 14.51 68
Implanted device (pacemaker/ICD) 136/53
Side of implantation (left/right) 122/67
Resynchronization therapy (yes/no) 29/160
Presence of a previous TR (yes/no) 21/168
Lead-related endocarditis (yes/no) 78/111
Lead-related factors
Implant duration, months, mean  SD 62.36 58.51 90
Polarity (unipolar/bipolar) 16/103
Single/double coil defibrillating lead 12/36
Lead fixation (passive/active) 123/45
Removal-related factors
Number of extracted ventricular leads (1/2) 168/21
Removal tools
Traction only/traction and any additional tool 97/92
Traction only/traction and laser only 97/62
Traction only/traction and lasso only 97/20
Traction only/traction and laser and lasso 97/10
Laser sheath size (14-/16-F) 31/43
Removal (complete/incomplete) 170/19
I  confidence interval; ICD  implantable cardioverter-defibrillator; OR  odds ratio; TR  tricuhe 19 patients with TTR, 6 (31.6%) died, 2 of them from teart failure, 1 from pulmonary embolism after bone frac-
ure, 1 from severe sepsis not related to the device, and 2
rom neoplasia. In patients with TTR, 9 patients have been
reated for new (i.e., not present before lead removal)
ight-sided heart failure symptoms; surgical repair of the
ricuspid valve had to be performed in 2 of them. At last
EE evaluation, new right ventricular enlargement was
resent in 6 of 13 surviving patients (46%). We did not
bserve any significant progression of TTR magnitude over
ime. Right-sided heart failure symptoms occurred exclu-
ively in patients who had a severe TTR after lead removal.
Survival curves of patients with and without TTR are
hown in Figure 1. A nonsignificant increase in mortality
as observed in the TTR population (p  0.26). A similar
onsignificant trend was still observed after adjustment for
he pre-specified prognostic factors (HR: 2.07, 95% CI:
.78 to 5.48, p  0.14). Figure 2 summarizes the outcome
f the 19 patients with TTR.
iscussion
ur systematic study of patients undergoing percutaneous
emoval of ventricular leads with modern tools shows that
TR is not uncommon. It also shows, for the first time, that
he use of a laser sheath for lead removal, after failure of simple
raction, is the most powerful risk factor of subsequent TTR.
n long-term follow-up, patients with severe TTR have a high
ncidence of right-sided heart failure symptoms.
ncidence of TTR after lead removal. It is well known
Analysis
p Univariate p Multivariate OR (95% CI) Multivariate
0.01 0.02 3.38 (1.21–9.41)
19.53 0.82
0.52
0.74
8 0.32
5 0.26
0 0.63
63.33 0.03
1
1
0.3
0.006
7 0.001
3 0.001 0.004 9.43 (2.03–43.77)
0.15 0.15 4.45 (0.58–34.19)
0.06 0.02 13.10 (1.58–108.92)
0.8
0.43
gurgitation; TTR  traumatic tricuspid regurgitation.s
riate
TTR
10/9
.02
15/4
13/6
1/1
4/1
9/1
.96
1/9
0/2
11/1
12/7
2/1
2/1
2/2
2/2
5/8
16/3hat chronically implanted leads are embedded into adher-
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Lead Removal and Tricuspid Regurgitation June 9, 2009:2168–74nt fibrotic tissue, which can take place all along the course
f the lead, including the tricuspid valve (16,17). In a report
f 2 cases of lead extraction performed by traction, TEE
howed traumatic rupture of papillary muscle head or of
ultiple chordae tendineae (7). However, traumatic lesions
f the tricuspid apparatus complicating extraction of pace-
aker ventricular leads have been reported rarely in the
odern era of lead extractions (4–9,14). This complication
ight be underestimated in the absence of systematic
ltrasound evaluation of the tricuspid valve (7). In the study
y Sohail et al. (14), 163 patients had percutaneous lead
Time (
Non-TTR
TTR
189
19 11 6 3
106 61 34
Su
rv
iv
al
1.0
0.8
0.6
0.4
0.2
0.0
0.00 12.00 24.00 36.00
Figure 1 Survival Curves of Patients With and Without TTR
Survival curves obtained before adjustment for pre-specified prognostic factors (se
Figure 2 Outcomes of the 19 Patients With Post-Removal Trau
HF  heart failure; TTR  traumatic tricuspid regurgitation.emoval for cardiac device infection. Of these, 3 had
ricuspid valve damage, requiring surgery in 2 cases. In the
tudy by Roux et al. (6), a severe tricuspid valvular damage
equiring surgery occurred in 1 of 177 procedures of lead
xtraction. However, the presence of a TTR was not system-
tically assessed in these studies. In a study of 43 patients by
oeffel et al. (8), systematic TEE evaluation performed during
ead extraction showed a 12% incidence of new severe TR in
he global population and a 17% incidence in case of lasing
cross and beyond the valve. Our systematic evaluation con-
rms and extends these results in a larger series of patients, in
hs)
1 --
4 1 Number of patients
still at trisk
Patients
without TTR
Patients
with TTR
60.00 72.00 84.00
P=0.26
Statistical Analysis section). TTR  traumatic tricuspid regurgitation.
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June 9, 2009:2168–74 Lead Removal and Tricuspid Regurgitationhom extraction was performed with a common set of
xtraction tools, including the lasso technique.
isk factors of TTR. The use of laser sheath alone or in
ssociation with the lasso technique seems to play an
mportant role in the occurrence of a further TTR. The
tudy by Roeffel et al. (8) emphasized an increased number
f TTRs in the laser group (4 of 23) than in the nonlaser
roup (1 of 20). However, this difference did not reach
tatistical significance, and the investigators suggested
tudying a larger number of patients. In our study, a causal
ole of the use of laser sheath in the occurrence of TTR is
ifficult to state because the use of such a tool was reserved
or difficult lead extractions, after failure of simple traction.
ailure of simple traction indicates important fibrosis along
he lead, which may involve the tricuspid valve. Our study
hows that in this situation, the dissection of tissues that is
erformed by the thermal energy does not rule out severe
alvular damage. Furthermore, as shown by multivariate
nalysis, the addition of the lasso technique, which some-
imes allows one to exert further traction on the lead, may
lso create valvular damage. On the other hand, because a
asso was mostly used, beyond simple traction, for removal
f leads already detached from the endocardium and pulled
nto the right atrium, it is not surprising that it is not an
ndependent predictor of TTR.
In our study, female sex is strongly associated with the
ccurrence of TTR. Byrd et al. (18,19) have shown that the
isk of major complications after extraction is higher for
omen. There is no clear explanation for this. A more
xtensive fibrotic reaction and/or more fragile tissues than in
en might be implicated.
Univariate analysis showed that more than 1 ventricular
ead removal and a longer lead implantation time were
ssociated with the occurrence of a subsequent TTR. Byrd
t al. (18) have already shown that the risk of major and
inor complications is proportional to the number of
emoved leads. A longer time from implantation has been
escribed as a predictor of extraction failure (4,18–20). We
an assume that TTR is probably the result of more
roblematic removal in these situations.
The most common class I indication for pacemaker lead
xtraction is a device-related infection (4,5,20). In our
tudy, the presence of a lead-related endocarditis did not
eem to be a predictor of subsequent TTR. It has been
hown (18,20) that the success rate of lead extraction was
ncreased in case of infected lead. A simpler removal of
nfected leads may be the explanation for less traumatic lead
emoval.
Fibrous tissue that grows into the grooves of the defibril-
ation coils of ICD leads (21) might result in more prob-
ematic lead extraction procedures (4). However, in accor-
ance with Roeffel et al. (8), we did not observe an increased
isk of TTR after ICD lead removal.
The majority of patients in this study had passive fixation
eads. There was a trend toward less frequent TTR after
ctive fixation lead removal (p  0.3). We cannot exclude phat if a higher proportion of active fixation leads were
ncluded in the study, the risk of TTR might have been
ower. However, consistent with our results, other investi-
ators did not show any difference in the outcomes of
xtraction procedures of active or passive leads (6,18).
utcome. Few data exist on the outcome of TR caused by
ail leaflet (22,23). In the series of 60 patients reported by
essika-Zeitoun et al. (23), it appears as a serious disease
ith a high event rate over time. Increased mortality,
ongestive heart failure, and right-sided chamber dilation
re emphasized by these investigators. This series differs
rom ours because the TR was not related to lead removal.
owever, the mechanism of TR did not influence the
utcome (23). The incidence and rate of occurrence of heart
ailure symptoms seem higher in our study than in the one
f Messika-Zeitoun et al. (23). This poorer outcome might
ave been influenced by a much older age in our population
nd by associated comorbidities, including right ventricular
acing. It is not explained by the presence of a previous
nderlying heart disease because the great majority of TTR
atients had no severe heart disease. In the study by Sohail
t al. (14), TTR required surgery in 2 of 3 cases. However,
he severity of this complication might have been overesti-
ated if only severely symptomatic patients were diagnosed.
tudy limitations. The limited number of TTR events and
eaths might have been critical for statistical analysis.
owever, to overcome this potential problem, the multivar-
ate analysis included only a limited number of risk factors.
imilarly, the adjusted effect of TTR on overall mortality
as assessed in a Cox proportional hazards model including
nly 4 pre-defined prognostic factors. Nevertheless, larger
eries are needed for further analysis of possible risk factors
nd natural history.
Some tools, such as nonpowered and electrosurgical
issection sheaths, are not used in our center and may merit
valuation.
Our data did not include information on the eventual site
f lasing along the lead course. Therefore, we could not
valuate the role of this factor. However, from a practical
oint of view, this factor seems difficult to control because
asing is commonly performed as far as possible along the
ead until the lead can be detached from the endocardium,
r laser sheath progression is no longer possible.
Our study protocol was designed to detect TTR occur-
ing early after lead removal to allow a close relationship
etween the procedure and the new TTR. Therefore,
lthough unlikely, TTR that might have occurred later
ould not have been diagnosed.
onclusions and Clinical Implications
TR is a possible complication after percutaneous ventric-
lar lead removal. The risk of this complication should
nfluence the decision regarding ventricular lead removal
hen the indication is not mandatory. Some pre-removal
arameters help to anticipate the complication: female
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mplantation. However, the strongest risk factor is related
o the use of specific extraction tools, because of failure of
imple traction, and therefore cannot be anticipated. The
atural history of this complication is not benign, mean-
ng that a clear recognition and a careful follow-up are
andatory.
eprint requests and correspondence: Dr. Jean-Claude Deharo,
HU La Timone Adultes, Cardiologie 9ème étage, 264 Rue Saint
ierre, 13385 Marseille Cédex 5, France. E-mail: jean-claude.
eharo@ap-hm.fr.
EFERENCE
1. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators:
expanding indications and technologies. JAMA 2006;295:809–18.
2. Birnie D, Williams K, Guo A, et al. Reasons for escalating pacemaker
implants. Am J Cardiol 2006;98:93–7.
3. Byrd CL, Schwartz SJ, Hedin N. Intravascular techniques for extrac-
tion of permanent pacemaker leads. J Thorac Cardiovasc Surg 1991;
101:989–97.
4. Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads.
Pacing Clin Electrophysiol 2008;31:736–52.
5. Wilkoff BL, Byrd CL, Love CJ, et al. Pacemaker lead extraction with
the laser sheath: results of the pacing lead extraction with the excimer
sheath (PLEXES) trial. J Am Coll Cardiol 1999;33:1671–6.
6. Roux JF, Pagé P, Dubuc M, et al. Laser lead extraction: predictors of
success and complications. Pacing Clin Electrophysiol 2007;30:
214–20.
7. Assayag P, Thuaire C, Benamer H, Sebbah J, Leport C, Brochet E.
Partial rupture of the tricuspid valve after extraction of permanent
pacemaker leads: detection by transesophageal echocardiography. Pac-
ing Clin Electrophysiol 1999;22:971–4.
8. Roeffel S, Bracke F, Meijer A, et al. Transesophageal echocardio-
graphic evaluation of tricuspid valve regurgitation during pacemaker
and implantable cardioverter defibrillator lead extraction. Pacing Clin
Electrophysiol 2002;25:1583–6.
9. Lee ME, Chaux A, Matloff JM. Avulsion of a tricuspid valve leaflet
during traction on an infected, entrapped endocardial pacemaker
electrode. The role of electrode design. J Thorac Cardiovasc Surg
1977;74:433–5. t0. Love CJ, Wilkoff BL, Byrd CL, et al. Recommendations for extraction
of chronically implanted transvenous pacing and defibrillator leads:
indications, facilities, training. Pacing Clin Electrophysiol 2000;23:
544–51.
1. Thuny FT, Disalvo G, Belliard O, et al. Risk of embolism and death
in infective endocarditis: prognostic value of echocardiography. a
prospective multicenter study. Circulation 2005;112:69–75.
2. Durack DT, Lukes AS, Bright DK. Duke endocarditis service. New
criteria for diagnosis of infective endocarditis: utilization of specific
echocardiographic findings. Am J Med 1994;96:200–9.
3. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to
endocarditis on pacemaker leads: clinical presentation and manage-
ment. Circulation 1997;95:2098–107.
4. Sohail MR, Uslan DZ, Khan AK, et al. Management and outcome of
permanent pacemaker and implantable cardioverter-defibrillator infec-
tions. J Am Coll Cardiol 2007;49:1851–9.
5. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations
for evaluation of the severity of native valvular regurgitation with
two-dimensional and Doppler echocardiography. J Am Soc Echocar-
diogr 2003;16:777–802.
6. Candinas R, Duru F, Schneider J, et al. Postmortem analysis of
encapsulation around long-term ventricular endocardial pacing leads.
Mayo Clin Proc 1999;74:120–5.
7. Robboy SJ, Harthorne JW, Leinbach RC, et al. Autopsy findings with
permanent pervenous pacemakers. Circulation 1969;39:495–501.
8. Byrd CL, Wilkoff BL, Love CJ, et al. Intravascular extraction of
problematic or infected permanent pacemaker leads: 1994–1996. U.S.
Extraction Database, MED Institute. Pacing Clin Electrophysiol
1999;22:1348–57.
9. Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Reiser C. Clinical study
of the laser sheath for lead extraction: the total experience in the
United States. Pacing Clin Electrophysiol 2002;25:804–8.
0. Bracke F, Meijer A, Van Gelder B. extraction of pacemaker and
implantable cardioverter defibrillator leads: patient and lead character-
istics in relation to the requirement of extraction tools. Pacing Clin
Electrophysiol 2002;25:1037–40.
1. Epstein AE, Kay GN, Plumb VJ, Dailey SM, Anderson PG. Gross
and microscopic pathological changes associated with nonthoracotomy
implantable defibrillator leads. Circulation 1998;98:1517–24.
2. van Son JAM, Danielson GK, Schaff HV, Miller FA. Traumatic
tricuspid valve insufficiency. J Thorac Cardiovasc Surg 1994;108:
893–8.
3. Messika-Zeitoun D, Thomson H, Bellamy M, et al. Medical and
surgical outcome of tricuspid regurgitation caused by flail leaflets.
J Thorac Cardiovasc Surg 2004;128:296–302.
ey Words: percutaneous lead removal y complication y traumatic
ricuspid regurgitation y flail leaflet.
